Delivery Order SPE2DB22D3016-SPE2DB26FAAL6
- Not listed
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 26, 2025, for Infuvite Adult Vial 10ML, a parenteral nutrition product. This firm fixed-price delivery order, valued at $1,285.82, is scheduled for completion by September 29, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a $6,014.17 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a child order under AmerisourceBergen's larger federal contract vehicle. The award was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $4,999.10 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Infuvite Adult Vial 10ml, a parenteral nutrition product. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and represents a non-competitive set-aside procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $6,378.08 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Infuvite Adult Vial 10ML, a parenteral nutrition product. This non-set-aside, firm fixed-price contract is scheduled for completion by June 2, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. AmerisourceBergen...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,214.08 for Infuvite Adult 10ML (5 units) by the Defense Logistics Agency's Medical Supply Chain on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract employs firm fixed-price pricing and was competitively awarded with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at approximately $61,000 to AmerisourceBergen Drug Corp for Infuvite Adult Bulk Vial 100ML, a parenteral nutrition product. This competitive, firm fixed-price delivery order was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Infuvite Pediatric Vial 5ML, a pediatric intravenous nutritional supplement. This firm fixed-price delivery order, valued at $31,264.79, represents a non-set-aside competitive award and is set for ultimate completion by July 1, 2025. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $31.5K delivery order to AmerisourceBergen Drug Corp for Infuvite Adult Bulk Vial 100ML, a sterile parenteral nutrition product commonly used in clinical settings for intravenous feeding. This competitively awarded, firm fixed-price delivery order was executed on July 14, 2025, with an ultimate completion date of July 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INFUVITE ADULT VIAL 10ML, an intravenous nutritional supplement product, valued at $11.5K. This non-competitive, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The order represents a child contract action under AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Infuvite Adult Vial 10ML, a pharmaceutical product used in clinical nutrition support. This firm fixed price delivery order has a ceiling value of $3,008.21 and is scheduled for completion by August 5, 2025. The award was competitively procured with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FAAL6Delivery Order
This delivery order, valued at $5,810.46, was awarded to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Infuvite Adult Vial 10ML, a parenteral nutrition product. The contract is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The Defense Logistics Agency, under the Department of Defense, funded this award. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal medical procurement requirements through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support, enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 10/23/25 |